21 insiders reported 368 Form 4 transactions for IONIS PHARMACEUTICALS INC (IONS) over the past 18 months (most recent 2026-09-02). Recent activity: BENNETT C FRANK (EVP, Chief Scientific Officer) Buy 110 shares, Monia Brett P (Chief Executive Officer) Buy 98 shares, O'NEIL PATRICK R. (EVP CLO & General Counsel) Buy 63 shares, Birchler Brian (EVP, Corp and Development Ops) Buy 58 shares, Hayden Michael R (Director) Buy 15,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-02 | BENNETT C FRANK | EVP, Chief Scientific Officer | Buy | 110 | $5,644 |
| 2026-09-02 | Monia Brett P | Chief Executive Officer | Buy | 98 | $5,028 |
| 2026-09-02 | O'NEIL PATRICK R. | EVP CLO & General Counsel | Buy | 63 | $3,232 |
| 2026-09-02 | Birchler Brian | EVP, Corp and Development Ops | Buy | 58 | $2,976 |
| 2026-07-31 | Hayden Michael R | Director | Buy | 15,000 | $800,700 |
| 2026-07-31 | Hayden Michael R | Director | Buy | 5,000 | $258,000 |
| 2026-07-17 | BERTHELSEN SPENCER R | Director | Buy | 5,220 | $0 |
| 2026-07-17 | HERMAN JOAN E | Director | Buy | 5,220 | $0 |
| 2026-07-09 | BENNETT C FRANK | EVP, Chief Scientific Officer | Sell | 5,536 | $462,693 |
| 2026-07-09 | Diaz Allene M. | Director | Buy | 10,111 | $476,329 |
| 2026-07-09 | Kordasiewicz Holly B. | EVP, Chief Development Officer | Sell | 362 | $30,517 |
| 2026-07-09 | BENNETT C FRANK | EVP, Chief Scientific Officer | Buy | 15,000 | $0 |
| 2026-07-09 | Diaz Allene M. | Director | Sell | 10,111 | $863,637 |
| 2026-07-09 | BENNETT C FRANK | EVP, Chief Scientific Officer | Sell | 15,000 | $1.3M |
| 2026-07-06 | KLEIN JOSEPH III | Director | Buy | 11,518 | $460,029 |
| 2026-07-06 | KLEIN JOSEPH III | Director | Sell | 99 | $7,866 |
| 2026-07-06 | KLEIN JOSEPH III | Director | Sell | 11,419 | $902,551 |
| 2026-06-30 | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Sell | 26,000 | $2.1M |
| 2026-06-30 | Baroldi Joseph | EVP, Chief Business Officer | Buy | 1,769 | $57,669 |
| 2026-06-30 | Baroldi Joseph | EVP, Chief Business Officer | Sell | 5,635 | $451,702 |
| 2026-06-30 | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Buy | 26,000 | $1.6M |
| 2026-06-30 | Baroldi Joseph | EVP, Chief Business Officer | Buy | 3,866 | $219,511 |
| 2026-06-30 | O'NEIL PATRICK R. | EVP CLO & General Counsel | Sell | 3,069 | $245,520 |
| 2026-06-26 | Monia Brett P | Chief Executive Officer | Buy | 14,565 | $474,819 |
| 2026-06-26 | Monia Brett P | Chief Executive Officer | Sell | 14,565 | $1.1M |
来源：SEC Form 4 申报文件 · 截至 2026-09-02